The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

US companies allow stem cell banking

| | June 17, 2013

The following is an excerpt.

Stem cells, the precursors to other kinds of cells in the human body, promise near-miracle medical treatments such as regenerating organs or repairing nerves. But stem cell medicine is still in the early stages. Culturing the right kind of cell remains difficult and so far only a few procedures are FDA-approved.

For those who want to be ready for that day, some companies in the United States are offering people a chance to bank their stem cells for future use.

Read the full story here: Bank Your Stem Cells for Future Use

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend